We look forward to sharing the knowledge and expertise of this wonderful National Keynote Speaker line up at the inaugural Virtual Scientific Meeting 2021 of Australian Pain Society.
All speakers will be joining us live for interactive sessions
that will include time for Q&A with delegates.
Tuesday 20 April, 10.25 – 10.45am
The somatostatin 4 receptor is a novel target for evoking pain relief in a rat model of chronic mechanical low back pain
Maree Smith AC, is Emeritus Professor and Director of the Centre for Integrated Preclinical Drug Development (CIPDD) in the School of Biomedical Sciences at The University of Queensland. Internationally, she is a leading researcher in biomedical discovery/translation with particular expertise in the novel pain therapeutics field. She is inventor on a patented novel analgesic technology that was licensed to the UQ spin-out company, Spinifex Pharmaceuticals, for commercialization and acquired by Novartis in 2015. Although her focus is on IP-sensitive research, she has maintained an excellent publication output, with 170 publications to date. She has also advised/co-advised 30 PhD students and 50 Research Masters/Honours students to completion, as well as mentored numerous researchers in the past three decades
Registrations are now open. Visit the APS 2021 website for more updates.
Follow us on Twitter with: #AusPainSoc
@AusPainSoc @MareeSmith19
Australian Pain Society 